Source: http://www.google.com/patents/US6353759?dq=7,292,151
Timestamp: 2014-12-26 01:55:13
Document Index: 283950118

Matched Legal Cases: ['application No. 09', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115', 'art 115']

Patent US6353759 - Cardiac rhythm management system promoting a trial pacing - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inAdvanced Patent SearchPatentsA cardiac rhythm management system includes an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter includes an infinite impulse response (IIR) or other filter that controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at an APP-indicated...http://www.google.com/patents/US6353759?utm_source=gb-gplus-sharePatent US6353759 - Cardiac rhythm management system promoting a trial pacingAdvanced Patent SearchPublication numberUS6353759 B1Publication typeGrantApplication numberUS 09/693,402Publication dateMar 5, 2002Filing dateOct 20, 2000Priority dateMay 21, 1999Fee statusPaidAlso published asUS6351669, WO2000071201A1Publication number09693402, 693402, US 6353759 B1, US 6353759B1, US-B1-6353759, US6353759 B1, US6353759B1InventorsJesse W. Hartley, Andrew P. Kramer, Jeffrey E. Stahmann, David B. KrigOriginal AssigneeCardiac Pacemakers, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (98), Non-Patent Citations (10), Referenced by (18), Classifications (13), Legal Events (4) External Links: USPTO, USPTO Assignment, EspacenetCardiac rhythm management system promoting a trial pacingUS 6353759 B1Abstract A cardiac rhythm management system includes an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter includes an infinite impulse response (IIR) or other filter that controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at an APP-indicated pacing rate that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythima, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
an atrial sensing circuit; a controller, the controller including: an A�A interval timer; a first register, for storing a first indicated pacing interval; a filter, updating the first indicated pacing interval based on the A�A interval timer and the first register; and an atrial therapy circuit, providing pacing therapy based at least partially on the first indicated pacing interval. 2. The system of claim 1, further including a sensor, and in which the controller further includes a second register, for storing a second indicated pacing interval that is based on a signal received from the sensor, and in which the atrial therapy circuit provides pacing therapy based on one or more of the first and second indicated pacing intervals.
3. The system of claim 1, in which the filter includes an infinite impulse response (IIR).
4. The system of claim 3, wherein the IIR filter updates the first indicated pacing interval (Tn) according to: Tn=A�AAn+B�Tn−1, if AAn is concluded by an intrinsic beat, otherwise is updated according to Tn=C�AAn+D�Tn−1, if AAn is concluded by a paced beat, where A, B, C and D are coefficients, and AAn is the A�A interval duration provided by the A�A interval timer, and Tn−1 is a previous value of the first indicated pacing interval, and wherein at least one of A, B, C or D is a function of heart rate.
5. The system of claim 4, in which Tn−1 is the immediately preceding value of the first indicated pacing interval.
6. The system of claim 1, in which the filter includes a finite impulse response (FIR).
7. The system of claim 1, in which the filter includes an averager.
8. The system of claim 7, in which the filter includes a weighted averager.
9. The system of claim 1, further comprising a remote programmer, adapted for communication with the controller.
10. The system of claim 1, wherein the filter updates the first indicated pacing interval (Tn) according to Tn=a�w�AAn+(1−w)�Tn−1, where a and w are coefficients, AAn is a most recent A�A interval duration, and Tn−1 is a previous value of the first indicated pacing interval.
11. The system of claim 10, in which Tn−1 is the immediately preceding value of the first indicated pacing interval.
12. The system of claim 1, wherein the filter updates the first indicated pacing interval (Tn) according to: Tn=a�w�AAn+(1−w)�Tn−1, if AAn is concluded by an intrinsic beat, otherwise is carried out according to Tn=b�w�AAn+(1−w)�Tn−1, if AAn is concluded by a paced beat, where b is a coefficient.
13. The system of claim 12, wherein at least one of a, b, or w is a function of heart rate.
14. The system of claim 1, wherein the controller obtains A�A intervals between atrial beats and computes a first indicated pacing interval based at least on a most recent A�A interval duration and a previous value of the first indicated pacing interval.
15. The system of claim 14, wherein the controller adjusts the first indicated pacing interval, by differently weighting at least one of (1) the most recent A�A interval duration, or (2) the previous value of the first indicated pacing interval, if the most-recent A�A interval is concluded by a paced beat than if the most recent A�A interval is concluded by a sensed beat.
16. The system of claim 14, wherein the controller computes the first indicated pacing interval (Tn) according to: Tn=a�w�AAn+(1−w)�Tn−1, if AAn is concluded by an intrinsic beat, otherwise Tn is computed according to Tn=b�w�AAn+(1−w)�Tn−1, if AAn is concluded by a paced beat, where b is a coefficient.
17. The system of claim 16, wherein at least one of a, b, or w is a function of heart rate.
18. The system of claim 1, further including a sensor, and in which the controller computes a second indicated pacing interval based on signals received from the sensor, and in which the atrial therapy circuit provides pacing therapy that is also based on the second indicated pacing interval.
19. The system of claim 1, in which the atrial therapy circuit provides pacing therapy at a rate that generally exceeds an intrinsic atrial heart rate.
20. The system of claim 19, in which the first register stores an immediately preceding value of the first indicated pacing interval.
21. An implantable cardiac rhythm management device, including:
an atrial sensing circuit; an atrial therapy circuit, providing atrial pacing therapy based on a first indicated pacing interval; a controller, the controller including: an A�A interval timer; a first register, for storing the first indicated pacing interval; and an infinite impulse response (IIR) filter that updates the first indicated pacing interval (Tn) according to: Tn=A�AAn+B�Tn−1, if AAn is concluded by an intrinsic beat, otherwise is updated according to Tn=C�AAn+D�Tn−1, if AAn is concluded by a paced beat, where A, B, C and D are coefficients, and AAn is the A�A interval duration provided by the A�A interval timer, and Tn−1 is the previous value of the first indicated pacing interval. 22. The implantable cardiac rhythm management device of claim 21, wherein at least one of A, B, C or D is a function of heart rate and C and D are different values.
23. The implantable cardiac rhythm management device of claim 22, wherein C and A are different values.
24. The system of claim 21, in which the atrial therapy circuit provides pacing therapy at a rate that generally exceeds an intrinsic atrial heart rate.
25. The system of claim 24, in which the first register stores an immediately preceding value of the first indicated pacing interval.
26. The system of claim 21, in which Tn−1 is the immediately preceding value of the first indicated pacing interval.
CROSS REFERENCE TO RELATED APPLICATIONS This application is a division of U.S. patent application No. 09/316,682, filed on May 21, 1999, entitled �CARDIAC RHYTHM MANAGEMENT SYSTEM PROMOTING ATRIAL PACING�, the specification of which is incorporated herein by reference. This application is related to the following co-pending, commonly assigned patent applications: U.S. patent application Ser. No. 09/316,515, filed on May 21, 1999, entitled, �METHOD AND APPARATUS FOR TREATING IRREGULAR VENTRICULAR CONTRACTIONS SUCH AS DURING ATRIAL ARRHYTHMIA�, U.S. patent application Ser. No. 09/316,741, filed on May 21, 1999, entitled, �CARDIAC RHYTHM MANAGEMENT SYSTEM WITH ATRIAL SHOCK TIMING OPTIMIZATION�, and U.S. patent application Ser. No. 09/316,588, filed on May 21, 1999, entitled, �SYSTEM PROVIDING VENTRICULAR PACING AND BIVENTRICULAR COORDINATION�, the specifications of which are incorporated herein by reference.
TECHNICAL FIELD This invention relates generally to cardiac rhythm management systems and particularly, but not by way of limitation, to a cardiac rhythm management system promoting atrial pacing.
BACKGROUND When functioning properly, the human heart maintains its own intrinsic rhythm, and is capable of pumping adequate blood throughout the body's circulatory system. However, some people have irregular cardiac rhythms, referred to as cardiac arrhythmias. Such arrhythmias result in diminished blood circulation. One mode of treating cardiac arrhythmias uses drug therapy. Drug therapy is not always effective for treating arrhythmias of certain patients. For such patients, an alternative mode of treatment is needed. One such alternative mode of treatment includes the use of a cardiac rhythm management system. Such systems are often implanted in the patient and deliver therapy to the heart.
An even more serious problem, however, is the risk that atrial fibrillation may induce irregular ventricular heart rhythms by processes that are yet to be fully understood. Such induced ventricular arrhythmias compromise pumping efficiency even more drastically than atrial arrhythmias and, in some instances, may be life-threatening. Moreover, treating atrial fibrillation by a defibrillation shock may also induce dangerous ventricular arrhythmias. For these and other reasons, there is a need for safe and more effective atrial therapy that prevents the occurrence of atrial tachyarrhytlnias, such as atrial fibrillation, thereby avoiding inducing ventricular arrhythmia as the result of the atrial tachyarrhythmia or its treatment.
SUMMARY This document discloses, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP-indicated rate is increased until it becomes slightly faster than the intrinsic atrial heart rate of the sensed atrial beat. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again elevates the APP-indicated pacing rate until it is above the intrinsic heart atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This is believed to decrease the likelihood of the occurrence of an atrial tachyarrhytnia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
In one embodiment, the cardiac rhythm management system includes a method comprising: (1) obtaining A�A intervals between atrial beats, (2) computing a first indicated pacing interval based at least on a most recent A�A interval duration and a previous value of the first indicated pacing interval, and (3) providing atrial pacing therapy, based on the first indicated pacing interval.
In another embodiment, the cardiac rhythm management system includes an atrial sensing circuit, an atrial therapy circuit, and a controller. The controller includes an A�A interval timer, a first register, for storing a first indicated pacing interval, and a filter, updating the first indicated pacing interval based on the A�A interval timer and the first register. The atrial therapy circuit provides pacing therapy based at least partially on the first indicated pacing interval. Other aspects of the invention will be apparent on reading the following detailed description of the invention and viewing the drawings that form a part thereof, each of which are not to be taken in a limiting sense; the scope of the present invention is defined by the appended claims and their equivalents.
FIG. 10 is a graph illustrating generally one embodiment of operating a filter to provide a first indicated rate, such as an Atrial Pacing Preference (�APP�) indicated rate, for successive atrial heart beats.
FIG. 11 is a graph illustrating generally another embodiment of operating a filter to provide a first indicated pacing rate, such as an APP indicated rate, and delivering therapy based on the first indicated pacing rate and based on a second indicated pacing rate, such as a sensor indicated rate.
FIG. 12 is a graph illustrating generally one embodiment of using at least one of coefficients a and b as a function of heart rate (or a corresponding time interval).
GENERAL OVERVIEW This document describes, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing over atrial sensing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated pacing rate, that is typically at a small amount above the intrinsic atrial heart rate. The APP-indicated rate is slowly decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter increases the pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
EXAMPLE EMBODIMENTS FIG. 1 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of portions of a cardiac rhythm management system 100 and an environment in which it is used. In FIG. 1, system 100 includes an implantable cardiac rhythm management device 105, also referred to as an electronics unit, which is coupled by an intravascular endocardial lead 110, or other lead, to a heart 115 of patient 120. System 100 also includes an external programmer 125 providing wireless communication with device 105 using a telemetry device 130. Catheter lead 110 includes a proximal end 135, which is coupled to device 105, and a distal end 140, which is coupled to one or more portions of heart 115.
FIG. 2 is a schematic drawing illustrating, by way of example, but not by way of limitation, one embodiment of device 105 coupled by one or more leads, such as leads 110A-B, to heart 115, which includes a right atrium 200A, a left atrium 200B, a right ventricle 205A, a left ventricle 205B, and a coronary sinus 220 extending from right atrium 200A. In this embodiment, atrial lead 110A includes electrodes (electrical contacts) disposed in, around, or near right atrium 200A of heart 115, such as ring electrode 225 and tip electrode 230, for sensing signals and/or delivering pacing therapy to the right atrium 200A. Lead 110A optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115.
In FIG. 2, a ventricular lead 110B includes one or more electrodes, such as tip electrode 235 and ring electrode 240, for sensing signals and/or delivering pacing therapy. Lead 110B optionally also includes additional electrodes, such as for delivering atrial and/or ventricular cardioversion/defibrillation and/or pacing therapy to heart 115. Device 105 includes components that are enclosed in a hermetically-sealed can 250. Additional electrodes may be located on the can 250, or on an insulating header 255, or on other portions of device 105, for providing unipolar pacing and/or defibrillation energy in conjunction with the electrodes disposed on or around heart 115. Other forms of electrodes include meshes and patches which may be applied to portions of heart 115 or which may be implanted in other areas of the body to help �steer� electrical currents produced by device 105. The present method and apparatus will work in a variety of configurations and with a variety of electrical contacts or �electrodes.�
EXAMPLE CARDIAC RHYTHM MANAGEMENT DEVICE FIG. 3 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of portions of device 105, which is coupled to heart 115. Device 105 includes a power source 300, an atrial sensing circuit 305, an atrial therapy circuit 310, and a controller 325. Device 105 also optionally includes a ventricular sensing circuit 315 and a ventricular therapy circuit 320.
Atrial sensing circuit 305 is coupled by atrial lead 110A to heart 115 for receiving, sensing, and/or detecting electrical atrial heart signals. Such atrial heart signals include atrial activations (also referred to as atrial depolarizations or P-waves), which correspond to atrial contractions. Such atrial heart signals include normal atrial rhythms, and abnormal atrial rhythms including atrial tachyarrhythmias, such as atrial fibrillation, and other atrial activity. Atrial sensing circuit 305 provides one or more signals to controller 325, via node/bus 327, based on the received atrial heart signals. Such signals provided to controller 325 indicate, among other things, the presence of sensed intrinsic atrial heart contractions.
Atrial therapy circuit 310 provides atrial pacing therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115 for obtaining resulting evoked atrial depolarizations. In one embodiment, atrial therapy circuit 310 also provides cardioversion/defibrillation therapy, as appropriate, to electrodes located at or near one of the atria 200 of heart 115, for terminating atrial fibrillation and/or other atrial tachyarrhythmias.
Ventricular sensing circuit 315 is coupled by ventricular lead 110B to heart 115 for receiving, sensing, and/or detecting electrical ventricular heart signals, such as ventricular activations (also referred to as ventricular depolarizations or R-waves), which correspond to ventricular contractions. Such ventricular heart signals include normal ventricular rhythms, and abnormal ventricular rhythms, including ventricular tachyarrhythmias, such as ventricular fibrillation, and other ventricular activity, such as irregular ventricular contractions resulting from conducted signals from atrial fibrillation. Ventricular sensing circuit 315 provides one or more signals to controller 325, via node/bus 327, based on the received ventricular heart signals. Such signals provided to controller 325 indicate, among other things, the presence of ventricular depolarizations, whether regular or irregular in rhythm.
Controller 325 controls the delivery of therapy by atrial therapy circuit 310, ventricular therapy circuit 320, and/or other circuits, based on heart activity signals received from atrial sensing circuit 305 and ventricular sensing circuit 315, as discussed below. Controller 325 includes various modules, which are implemented either in hardware or as one or more sequences of steps carried out on a microprocessor or other controller. Such modules are illustrated separately for conceptual clarity; it is understood that the various modules of controller 325 need not be separately embodied, but may be combined and/or otherwise implemented, such as in software/firmware.
In general terms, sensing circuits 305 and 310 sense electrical signals from heart tissue in contact with the catheter leads 110A-B to which these sensing circuits 305 and 310 are coupled. Sensing circuits 305 and 310 and/or controller 325 process these sensed signals. Based on these sensed signals, controller 325 issues control signals to therapy circuits, such as atrial therapy circuit 310 and/or ventricular therapy circuit 320, if necessary, for the delivery of electrical energy (e.g., pacing and/or defibrillation pulses) to the appropriate electrodes of leads 110A-B. Controller 325 may include a microprocessor or other controller for execution of software and/or firmware instructions. The software of controller 325 may be modified (e.g., by remote external programmer 105) to provide different parameters, modes, and/or functions for the implantable device 105 or to adapt or improve performance of device 105.
FIG. 4 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of controller 325 that includes several different inputs to modify the rate at which pacing or other therapy is delivered. For example, Input #1 may provide information about atrial heart rate, Input #2 may provide information about ventricular heart rate, Input #3 may provide an accelerometer-based indication of activity, and Input #4 may provide an impedance-based indication of respiration, such as minute ventilation. Based on at least one of these and/or other inputs, controller 325 provides an output indication of pacing rate as a control signal delivered to a therapy circuit, such as to one or more of atrial therapy circuit 310 and ventricular therapy circuit 320. Atrial therapy circuit 310 and ventricular therapy circuit 320 issue pacing pulses based on one or more such control signals received from controller 325. Control of the pacing rate may be performed by controller 325, either alone or in combination with peripheral circuits or modules, using software, hardware, firmware, or any combination of the like. The software embodiments provide flexibility in how inputs are processed and may also provide the opportunity to remotely upgrade the device software while still implanted in the patient without having to perform surgery to remove and/or replace the device 105.
CONTROLLER EXAMPLE 1 FIG. 5 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, one conceptualization of portions of controller 325. At least one signal from atrial sensing circuit 305 is received by atrial event module 500, which recognizes the occurrence of atrial events included within the signal. Such events are also referred to as �beats,� �activations,� �depolarizations,� �P-waves,� or �contractions.� Atrial event module 500 detects intrinsic events (also referred to as sensed events) from the signal obtained from atrial sensing circuit 305. Atrial event module 500 also detects evoked events (resulting from a pace) either from the signal obtained from atrial sensing circuit 305, or preferably from an atrial pacing control signal obtained from pacing control module 505, which also triggers the delivery of a pacing stimulus by atrial therapy circuit 310. Thus, atrial events include both intrinsic/sensed events and evoked/paced events.
A time interval between successive atrial events, referred to as an A�A interval, is recorded by a first timer, such as A�A interval timer 510. A filter 515 computes a �first indicated pacing interval,� i.e., one indication of a desired time interval between atrial events or, stated differently, a desired atrial heart rate. The first indicated pacing interval is also referred to as an atrial pacing preference (APP) indicated pacing interval. In various embodiments, filter 515 includes an averager, a weighted averager, a median filter, an infinite impulse (IIR) filter, a finite impulse response (FIR) filter, or any other analog or digital signal processing circuit providing the desired signal processing described more particularly below.
In one embodiment, filter 515 computes a new value of the first indicated pacing interval (also referred to as the APP-indicated pacing interval) based on the duration of the most recent A�A interval recorded by timer 510 and on a previous value of the first indicated pacing interval stored in first indicated pacing interval register 520. Register 520 is then updated by storing the newly computed first indicated pacing interval in register 520. Based on the first indicated pacing interval stored in register 520, pacing control module 505 delivers control signals to atrial therapy circuit 310 for delivering therapy, such as pacing stimuli, at the APP-indicated atrial heart rate corresponding to the inverse of the duration of the first indicated pacing interval.
FILTER EXAMPLE 1 In general terms, for one embodiment, device 105 obtains A�A intervals between successive sensed or evoked atrial beats. Device 105 computes a new first indicated pacing interval based at least in part on the duration of the most recent A�A interval and a previous value of the first indicated pacing interval. Device 105 provides atrial pacing therapy delivered at a rate corresponding to the inverse of the duration of the first indicated pacing interval.
FIG. 6 is a signal flow diagram illustrating generally, by way of example, but not by way of limitation, one embodiment of operating filter 515. Upon the occurrence of a sensed or evoked atrial beat, timer 510 provides filter 515 with the duration of the A�A interval concluded by that beat, which is referred to as the most recent A�A interval (AAn). Filter 515 also receives the previous value of the first indicated pacing interval (Tn−1) stored in register 520. The most recent A�A interval AAn and the previous value of the first indicated pacing interval Tn−1 are each scaled by respective constants A and B, and then summed to obtain a new value of the first indicated pacing interval (Tn), which is stored in register 520 and provided to pacing control module 505. In one embodiment, the coefficients A and B are different values, and are either programmable, variable, or constant.
If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occurrence of the atrial beat concluding the most recent A�A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn. In one embodiment, operation of the filter is described by Tn=A�AAn+B�Tn−1, where A and B are coefficients (also referred to as �weights�), AAn is the most recent A�A interval duration, and Tn−1 is the previous value of the first indicated pacing interval.
FILTER EXAMPLE 2 In one embodiment, operation of filter 515 is based on whether the beat concluding the most recent A�A interval AAn is a sensed/intrinsic beat or a paced/evoked beat. In this embodiment, the pacing control module 505, which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A�A interval AAn was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
In general terms, if the most recent A�A interval AAn is concluded by a sensed/intrinsic beat, then filter 515 provides a new first indicated pacing interval Tn that is adjusted from the value of the previous first indicated pacing interval Tn−1 such as, for example, decreased by an amount that is based at least partially on the duration of the most recent A�A interval AAn and on the duration of the previous value of the first indicated pacing interval Tn−1. If, however, the most recent A�A interval AAn is concluded by a paced/evoked beat, then filter 515 provides a new first indicated pacing interval Tn that is increased from the value of the previous first indicated pacing interval Tn−1, such as, for example, by an amount that is based at least partially on the duration of the most recent A�A interval AAn and on the duration of the previous value of the first indicated pacing interval Tn−1. If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occurrence of the atrial beat concluding the most recent A�A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn.
FIG. 7 is a signal flow diagram, illustrating generally, by way of example, but not by way of limitation, another conceptualization of operating filter 515, with certain differences from FIG. 6 more particularly described below. In this embodiment, the pacing control module 505, which controls the timing and delivery of pacing pulses, provides an input to filter 515 that indicates whether the most recent A�A interval AAn was concluded by an evoked beat initiated by a pacing stimulus delivered by device 105, or was concluded by an intrinsic beat sensed by atrial sensing circuit 305.
If the most recent A�A interval AAn was concluded by an intrinsic beat, then the most recent A�A interval, AAn, and the previous value of the first indicated pacing interval, Tn−1, are each scaled by respective constants A and B, and then summed to obtain the new value of the first indicated pacing interval Tn, which is stored in register 520 and provided to pacing control module 505. Alternatively, if the most recent A�A interval AAn was concluded by an evoked/paced beat, then the most recent A�A interval AAn and the previous value of the first indicated pacing interval Tn−1 are each scaled by respective constants C and D, and then summed to obtain the new value of the first indicated pacing interval Tn, which is stored in register 520 and provided to pacing control module 505. In one embodiment, the coefficients C and D are different from each other, and are either programmable, variable, or constant. In a further embodiment, the coefficient C is a different value from the coefficient A, and/or the coefficient D is a different value than the coefficient B, and these coefficients are either programmable, variable, or constant. In another embodiment, the coefficient D is the same value as the coefficient B.
In one embodiment, operation of filter 515 is described by Tn=A�AAn+B�Tn−1, if AAn is concluded by an intrinsic beat, and is described by Tn=C�AAn+D�Tn−1, if AAn is concluded by a paced beat, where A, B, C and D are coefficients (also referred to as �weights�), AAn is the most recent A�A interval duration, Tn is the new value of the first indicated pacing interval, and Tn−1 is the previous value of the first indicated pacing interval. If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occurrence of the atrial beat concluding the most recent A�A interval AAn, then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn.
FILTER EXAMPLE 3 In another embodiment, these coefficients can be more particularly described using an intrinsic coefficient (a), a paced coefficient (b), and a weighting coefficient (w). In one such embodiment, A=a�w, B=(1−w), C=b�w, and D=(1−w). In one example, operation of the filter 515 is described by Tn=a�w�AAn+(1−w) �Tn−1, if AAn is concluded by an intrinsic beat, otherwise is described by Tn=b�w�AAn+(1−w)�Tn−1, if AAn is concluded by a paced beat, as illustrated generally, by way of example, but not by way of limitation, in the signal flow graph of FIG. 8. If no atrial beat is sensed during the new first indicated pacing interval Tn, which is measured as the time from the occurrence of the atrial beat concluding the most recent A�A interval AAn,then pacing control module 505 instructs atrial therapy circuit 310 to deliver an atrial pacing pulse upon the expiration of the new first indicated pacing interval Tn. In one embodiment, the coefficients a and b are different from each other, and are either programmable, variable, or constant.
The above-described parameters (e.g., A, B, C, D, a, b, w) are stated in terms of time intervals (e.g., AAn, Tn, Tn−1). However, an alternate system may produce results in terms of rate, rather than time intervals, without departing from the present method and apparatus. In one embodiment, weighting coefficient w, intrinsic coefficient a, and paced coefficient b, are variables. Different selections of w, a, and b, will result in different operation of the present method and apparatus. For example, as w increases the weighting effect of the most recent A�A interval AAn increases and the weighting effect of the previous first indicated pacing rate Tn−1 decreases. In one embodiment, w={fraction (1/16)}=0.0625. In another embodiment, w={fraction (1/32)}. Another possible range for w is from w=� to w={fraction (1/1024)}. A further possible range for w is from w≈0 to w≈1. Other values of w, which need not include division by powers of two, may be substituted without departing from the present method and apparatus.
In one embodiment, for a<1.0 filter 515 provides a new first indicated pacing interval Tn that is at least slightly shorter than the expected intrinsic A�A interval being measured by timer 515. Thus, filter 515 operates to promote atrial pacing by increasing the APP-indicated rate until it becomes slightly faster than the intrinsic atrial rate. The APP-indicated rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. After a sensed atrial beat, the APP filter 515 again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
CONTROLLER EXAMPLE 2 FIG. 9 is a schematic diagram illustrating generally, by way of example, but not by way of limitation, another conceptualization of portions of controller 325, with certain differences from FIG. 5 more particularly described below. In FIG. 9, controller 325 receives from sensor 330 a signal including information from which a physiologically desired heart rate (e.g., based on the patient's activity, respiration, or any other suitable indicator of metabolic need) can be derived. The sensor signal is digitized by an A/D converter 900. The digitized signal is processed by a sensor rate module 905, which computes a desired heart rate that is expressed in terms of a second indicated pacing interval stored in register 910. The second indicated pacing interval is also referred to as a sensor-indicated pacing interval, or if expressed in terms of rate, a sensor-indicated pacing rate.
Pacing control module 505 delivers a control signal, which directs atrial therapy circuit 310 to deliver a pacing pulse, based on either (or both) of the first or second indicated pacing intervals, stored in registers 520 and 910, respectively. In one embodiment, pacing control module 505 includes a selection module 915 that selects between the new first indicated pacing interval Tn and the sensor-based second indicated pacing interval.
In one embodiment, selection module 915 selects the shorter of the first and second indicated pacing intervals as the selected indicated pacing interval Sn. If no atrial beat is sensed during the selected indicated pacing interval Sn, which is measured as the time from the occurrence of the atrial beat concluding the most recent A�A interval AAn,then pacing control module 505 instructs atrial therapy circuit 320 to deliver an atrial pacing pulse upon the expiration of the selected indicated pacing interval Sn.
In general terms, for this embodiment, the atrium is paced at the higher of the sensor indicated rate and the APP-indicated rate. If, for example, the patient is resting, such that the sensor indicated rate is lower than the patient's intrinsic rate, then atrial pacing pulses will be delivered at the APP-indicated rate, which is typically slightly higher than the patient's intrinsic atrial heart rate. But if, for example, the patient is active, such that the sensor indicated rate is higher than the APP-indicated rate, then pacing pulses generally will be delivered at the sensor indicated rate. In an alternative embodiment, the pacing rate is determined by blending the sensor indicated rate and the APP-indicated rate, rather than by selecting the higher of these two indicated rates (i.e., the shorter of the first and second indicated pacing intervals). In one such example, selection module 915 applies predetermined or other weights to the first and second indicated pacing intervals to compute the selected pacing interval Sn.
FILTER RATE BEHAVIOR EXAMPLE 1 FIG. 10 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of an APP-indicated rate for successive atrial heart beats for one mode of operating filter 515. As discussed above, the APP-indicated rate is simply the frequency, between atrial heart beats, associated with the first indicated pacing interval. Stated differently, the APP indicated rate is inversely related to the duration of the first indicated pacing interval. If pacing is based solely on the APP indicated rate, pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse after the time since the last atrial beat equals or exceeds the first indicated pacing interval. However, as described above, in certain embodiments, pacing control module 505 directs atrial therapy circuit 310 to issue a pacing pulse based on factors other than the APP indicated rate such as for, example, based on the sensor indicated rate.
In the example illustrated in FIG. 10, a first paced atrial beat, indicated by a �P� was issued upon expiration of the first indicated pacing interval (i.e., the APP indicated pacing interval) T0, as computed based on a previous atrial beat. In one embodiment, the new APP indicated pacing interval T1 is computed based on the duration of most recent A�A interval AA1 and a previous value of the APP indicated pacing interval T0, as discussed above. In FIG. 10, the new APP indicated pacing interval T1 corresponds to a lower rate limit (LRL) time interval. In one embodiment, as illustrated in FIG. 10, the allowable range of the APP indicated pacing interval is limited so that the APP indicated pacing interval does not exceed the duration of the LRL time interval, and so that the APP indicated pacing interval is not shorter than the duration of an upper rate limit (URL) time interval.
In the example of FIG. 10, the second atrial beat is also paced upon expiration of the APP indicated pacing interval T1. In one embodiment, the new APP indicated pacing interval T2 is computed based on the duration of most recent A�A interval AA2 and a previous value of the APP indicated pacing interval, T1, as discussed above. The first and second atrial beats are paced beats because the APP indicated atrial heart rate is higher than the underlying intrinsic atrial heart rate.
The fourth, fifth, and sixth atrial beats are sensed before expiration of the APP indicated pacing interval T3, T4, and T5, respectively For each of the sensed fourth, fifth, and sixth atrial beats, filter 515 computes a new APP indicated pacing interval as being shorter in duration relative to the previous APP indicated pacing interval.
The fourteenth atrial beat is sensed before expiration of the APP indicated pacing interval T13, such that no pacing pulse is issued. For the sensed fourteenth atrial beat, filter 515 computes the new APP indicated pacing interval T14as being shorter in duration relative to the previous APP indicated pacing interval T13.
The intrinsic coefficient a of filter 515 controls the �attack slope� of the APP indicated heart rate as the APP indicated heart rate increases because of sensed intrinsic beats. The paced coefficient b of filter 515 controls the �decay slope� of the APP indicated heart rate as the APP indicated heart rate decreases during periods of paced beats. In one embodiment, in which a<1.0 and b>1.0, decreasing the value of a further beneath 1.0 increases the attack slope such that the APP indicated rate increases faster in response to sensed intrinsic beats, while decreasing the value of b toward 1.0 decreases the decay slope such that the APP indicated rate decreases more slowly during periods of paced beats. Conversely, for a<1.0 and b>1.0, increasing the value of a toward 1.0 decreases the attack slope such that the APP indicated rate increases more slowly in response to sensed intrinsic beats, while increasing the value of b from 1.0 increases the decay slope such that the APP indicated rate decreases more quickly during periods of paced beats.
In one embodiment, for a<1.0 and b>1.0, decreasing both a and b increases the APP indicated rate such that the APP indicated rate is higher above the mean intrinsic rate. Because the APP indicated rate is higher, variability in the intrinsic heart rate is less likely to result in sensed events. On the other hand, for a<1.0 and b>1.0, increasing both a and b decreases the APP indicated rate such that it is closer to, the mean intrinsic rate. Because the APP indicated rate is closer to the mean intrinsic rate, the same degree of variability in the intrinsic heart rate is more likely to result in sensed events. Thus, by optimizing the coefficients of filter 515, as discussed above, it is possible to obtain more intrinsic beats than paced beats for a particular degree of variability in the patient's heart rate. In one embodiment, these coefficients are programmable by the user, such as by using remote programmer 125. In another embodiment, the user selects a desired performance parameter (e.g., desired degree of overdrive pacing, desired attack slope, desired decay slope, etc.) from a corresponding range of possible values, and device 105 automatically selects the appropriate combination of coefficients of filter 515 to provide a filter setting that corresponds to the selected user-programmed performance parameter, as illustrated generally by Table 1. Other levels of programmability or different combinations of coefficients may also be used.
FILTER RATE BEHAVIOR EXAMPLE 2 FIG. 11 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of selecting between more than one indicated pacing interval. FIG. 11 is similar to FIG. 10 in some respects, but FIG. 11 includes a second indicated pacing interval. In one embodiment, the first indicated pacing interval is the APP indicated pacing interval, described above, and the second indicated pacing interval is a sensor indicated pacing interval, from an accelerometer, minute ventilation, or other indication of the patient's physiological need for increased cardiac output.
In one embodiment, a selected indicated pacing interval is based on the shorter of the first and second indicated pacing intervals. Stated differently, device 105 provides pacing pulses at the higher indicated pacing rate. In the example illustrated in FIG. 11, the first and second beats and the eighth through fifteenth beats are paced at the sensor indicated rate, because it is higher than the APP indicated atrial rate and the intrinsic (sensed) atrial rate. The third, fourth, fifth and sixth atrial beats are sensed intrinsic beats that are sensed during the shorter of either of the APP and sensor indicated pacing intervals. The seventh beat is paced at the APP indicated rate, because it is higher than the sensor indicated rate, and because no intrinsic beat is sensed during the APP indicated interval T6. In this embodiment, the ranges of both the sensor indicated rate and the APP indicated rate are limited so that they do not extend to rates higher than the URL or to rates lower than the LRL. In one embodiment, the above-described equations for filter 515 operate to increase the APP indicated rate toward the sensor-indicated rate when the sensor indicated rate is greater than the APP indicated rate, as illustrated by first through third and eighth through fifteenth beats in FIG. 11. In an alternate embodiment, however, Tn=b�w�AAn+(1−w)�Tn−1, if AAn is concluded by a APP indicated paced beat, and Tn =Tn−1 if AAn is concluded by a sensor indicated paced beat, thereby leaving the APP indicated rate unchanged for sensor indicated paced beats. In one embodiment, the LRL and the URL are programmable by the user, such as by using remote programmer 125.
FILTER EXAMPLE 3 In one embodiment, filter 515 includes variable coefficients such as, for example, coefficients that are a function of heart rate (or its corresponding time interval). In one example, operation of the filter 515 is described by Tn=a�w�AAn+(1−w)�Tn−1, if AAn is concluded by an intrinsic beat, otherwise is described by Tn=b�w�AAn+(1−w)�Tn−1, if AAn is concluded by a paced beat, where at least one of a and b are linear, piecewise linear, or nonlinear functions of one or more previous A�A intervals such as, for example, the most recent A�A interval, AAn.
FIG. 12 is a graph illustrating generally, by way of example, but not by way of limitation, one embodiment of using at least one of coefficients a and b as a function of one or more previous A�A intervals such as, for example, the most recent A�A interval, AAn. In one such example, a is less than 1.0 when AAn is at or near the lower rate limit (e.g., 1000 millisecond interval or 60 beats/minute), and a is greater than 1.0 when AAn is at or near the upper rate limit (e.g., 500 millisecond interval or 120 beats/minute). For a constant b, using a smaller value of a at lower rates will increase the pacing rate more quickly for sensed events; using a larger value of a at higher rates increases the pacing rate more slowly for sensed events. In another example, b is close to 1.0 when AA. is at or near the lower rate limit, and b is greater than 1.0 when AAn is at or near the upper rate limit. For a constant a, using a smaller value of b at lower rates will decrease the pacing rate more slowly for paced events; using a larger value of b at higher rates decreases pacing rate more quickly for paced events.
CONCLUSION The above-described system provides, among other things, a cardiac rhythm management system including an atrial pacing preference (APP) filter for promoting atrial pacing. The APP filter controls the timing of delivery of atrial pacing pulses. The atrial pacing pulses are delivered at a first indicated pacing rate, i.e., the APP-indicated rate, that is typically at a small amount above the intrinsic atrial heart rate. For sensed beats, the APP indicated pacing rate is increased until it becomes slightly faster than the intrinsic atrial heart rate. The APP-indicated pacing rate is then gradually decreased to search for the underlying intrinsic atrial heart rate. Then, after a sensed atrial beat, the APP filter again increases the APP indicated pacing rate until it becomes faster than the intrinsic atrial rate by a small amount. As a result, most atrial heart beats are paced, rather than sensed. This decreases the likelihood of the occurrence of an atrial tachyarrhythmia, such as atrial fibrillation. The decreased likelihood of atrial tachyarrhythmia, in turn, decreases the likelihood of inducing a ventricular arrhythmia, either as a result of the atrial tachyarrhythmia, or as the result of delivering a defibrillation shock to treat the atrial tachyarrhythmia.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3857399Mar 19, 1971Dec 31, 1974Zacouto FHeart pacerUS4030510Nov 5, 1975Jun 21, 1977General Electric CompanyStandby heart pacerUS4163451Oct 26, 1977Aug 7, 1979Cordis CorporationInteractive method and digitally timed apparatus for cardiac pacing arrhythmia treatmentUS4556063Dec 7, 1984Dec 3, 1985Medtronic, Inc.Telemetry system for a medical deviceUS4830006Jun 17, 1986May 16, 1989Intermedics, Inc.Implantable cardiac stimulator for detection and treatment of ventricular arrhythmiasUS4917115Jul 11, 1988Apr 17, 1990Vitatron Medical B. V.Pacing system and method for physiological stimulation of the heart utilizing Doppler meansUS4920965Nov 25, 1987May 1, 1990Medtronic, Inc.Dual chamber pacemaker with adaptive atrial escape intervalUS4928688Jan 23, 1989May 29, 1990Mieczyslaw MirowskiMethod and apparatus for treating hemodynamic disfunctionUS4998974Jan 5, 1990Mar 12, 1991Telectronics Pacing Systems, Inc.Apparatus and method for antitachycardia pacing in dual chamber arrhythmia control systemUS5085215Mar 20, 1990Feb 4, 1992Telectronics Pacing Systems, Inc.Metabolic demand driven rate-responsive pacemakerUS5127404Sep 25, 1991Jul 7, 1992Medtronic, Inc.Telemetry format for implanted medical deviceUS5129394Jan 7, 1991Jul 14, 1992Medtronic, Inc.Method and apparatus for controlling heart rate in proportion to left ventricular pressureUS5139020Mar 8, 1991Aug 18, 1992Telectronics Pacing Systems, Inc.Method and apparatus for controlling the hemodynamic state of a patient based on systolic time interval measurements detecting using doppler ultrasound techniquesUS5156154Mar 8, 1991Oct 20, 1992Telectronics Pacing Systems, Inc.Monitoring the hemodynamic state of a patient from measurements of myocardial contractility using doppler ultrasound techniquesUS5183040Mar 8, 1991Feb 2, 1993Telectronics Pacing Systems, Inc.Apparatus and method for detecting abnormal cardiac rhythms using an ultrasound sensor in an arrhythmia control systemUS5188106Mar 8, 1991Feb 23, 1993Telectronics Pacing Systems, Inc.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasoundUS5207219Oct 23, 1992May 4, 1993Incontrol, Inc.Atrial defibrillator and method for providing interval timing prior to cardioversionUS5282836Oct 23, 1992Feb 1, 1994Incontrol, Inc.Atrial defibrillator and method for providing pre-cardioversion pacingUS5284491Feb 27, 1992Feb 8, 1994Medtronic, Inc.Cardiac pacemaker with hysteresis behaviorUS5292339Apr 29, 1992Mar 8, 1994Telectronics Pacing Systems, Inc.Implantable pacemaker/cardioverter/defibrillator device and method incorporating multiple bradycardia support pacing ratesUS5312452Nov 3, 1992May 17, 1994Cardiac Pacemakers, Inc.Cardiac rhythm management device with automatic optimization of performance related pacing parametersUS5331966Dec 16, 1993Jul 26, 1994Medtronic, Inc.Subcutaneous multi-electrode sensing system, method and pacerUS5350409Apr 19, 1993Sep 27, 1994Vitatron Medical, B.V.Rate adaptive pacemaker with adjustment of sensor rate as a function of sensed sinus rateUS5365932Sep 2, 1993Nov 22, 1994Telectronics Pacing System, Inc.Cardiac signal sensing device having sensitivity automatically controlled in response to metabolic demandUS5383910Feb 19, 1993Jan 24, 1995Medtronic, Inc.Method and apparatus for tachyarrhythmia detection and treatmentUS5391189 *Nov 4, 1993Feb 21, 1995Vitatron Medical, B.V.Rate adaptive dual chamber pacing system and method with automatic adjustment of operating parameters for minimizing sensor-sinus competitionUS5395397Sep 9, 1993Mar 7, 1995Siemens Elema AbMethod and apparatus for stimulating a heartUS5400796Oct 22, 1993Mar 28, 1995Siemens-Elema AbDevice for identifying atrial depolarizationUS5411524Nov 2, 1993May 2, 1995Medtronic, Inc.Method and apparatus for synchronization of atrial defibrillation pulsesUS5411531Sep 23, 1993May 2, 1995Medtronic, Inc.Electrical medical stimulatorUS5417714May 11, 1993May 23, 1995Pacesetter, Inc.DDI pacing with PVC-protected hysteresis and automatic AV interval adjustmentUS5462060May 24, 1994Oct 31, 1995Ela Medical, S.A.Methods and apparatus for determining when tachyarrythmia is pace-terminableUS5480413Nov 30, 1994Jan 2, 1996Telectronics Pacing Systems, Inc.Apparatus and method for stabilizing the ventricular rate of a heart during atrial fibrillationUS5486198Aug 12, 1994Jan 23, 1996Ayers; Gregory M.Atrial defibrillator and method for providing interval timing of successive intervals prior to cardioversionUS5487752Nov 15, 1994Jan 30, 1996Cardiac Pacemakers, Inc.Automated programmable stimulating device to optimize pacing parameters and methodUS5507782Mar 17, 1994Apr 16, 1996Medtronic, Inc.Method and apparatus for dual chamber cardiac pacingUS5507784Apr 6, 1995Apr 16, 1996Medtronic, Inc.Method and apparatus for control of A-V intervalUS5514163Feb 21, 1995May 7, 1996Medtronic, Inc.Dual chamber pacing system and method with optimized adjustment of the AV escape interval for treating cardiomyopathyUS5522859Nov 22, 1994Jun 4, 1996Medtronic, Inc.Sinus preference method and apparatus for cardiac pacemakersUS5527347Feb 21, 1995Jun 18, 1996Medtronic, Inc.Dual chamber pacing system and method with automatic adjustment of the AV escape interval for treating cardiomyopathyUS5534016Feb 21, 1995Jul 9, 1996Vitatron Medical, B.V.Dual chamber pacing system and method utilizing detection of ventricular fusion for adjustment of the atrial-ventricular delay as therapy for hypertrophic obstructive cardiomyopathyUS5540727Nov 15, 1994Jul 30, 1996Cardiac Pacemakers, Inc.Method and apparatus to automatically optimize the pacing mode and pacing cycle parameters of a dual chamber pacemakerUS5545186Mar 30, 1995Aug 13, 1996Medtronic, Inc.Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmiasUS5560369Sep 22, 1994Oct 1, 1996Pacesetter, Inc.Cardiac arrhythmia detection system for an implantable stimulation device and methodUS5584864Jun 14, 1994Dec 17, 1996Incontrol, Inc.Cardioversion synchronization system and method for an atrial defibrillatorUS5584867Apr 4, 1995Dec 17, 1996Ela Medical S.A.Method and apparatus for controlling a double atrial triple chamber cardiac pacemaker having a fallback modeUS5626620Feb 21, 1995May 6, 1997Medtronic, Inc.Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathyUS5626623Apr 30, 1996May 6, 1997Medtronic, Inc.Method and apparatus for optimizing pacemaker AV delayUS5632267Aug 29, 1995May 27, 1997Pacesetter AbHeart defibrillator and defibrillation method wherein defibrillation is achieved by high-frequency, low-energy pulsesUS5674255Dec 14, 1995Oct 7, 1997Cardiac Pacemakers, Inc.Dual chamber pacer having automatic PVARPUS5690689Mar 29, 1996Nov 25, 1997Pacesetter, Inc.Dual-chamber implantable stimulation device having adaptive AV intervall and method for treating cardiomyopathy thereofUS5700283Nov 25, 1996Dec 23, 1997Cardiac Pacemakers, Inc.Method and apparatus for pacing patients with severe congestive heart failureUS5713929May 3, 1996Feb 3, 1998Medtronic, Inc.Arrhythmia and fibrillation prevention pacemaker using ratchet up and decay modes of operationUS5713932Oct 28, 1996Feb 3, 1998Medtronic, Inc.Method and apparatus for determining atrial lead disclocation and confirming diagnosis of atrial tachyarrhythimiasUS5716383Jun 24, 1996Feb 10, 1998Medtronic, Inc.Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathyUS5725561Jun 9, 1995Mar 10, 1998Medtronic, Inc.Cardiac pulse delivery and sensing apparatusUS5730141Jun 7, 1996Mar 24, 1998Pacesetter, Inc.Tachyarrhythmia detection methodUS5730142Mar 21, 1997Mar 24, 1998Medtronic, Inc.Method and apparatus for detecting tachycardiaUS5738096Feb 1, 1996Apr 14, 1998Biosense, Inc.Cardiac electromechanicsUS5741308May 15, 1995Apr 21, 1998Pacesetter, Inc.Dual-chamber implantable pacemaker and method of operating same for automatically setting the pacemaker's AV interval as a function of a natural measured conduction timeUS5749906Dec 3, 1996May 12, 1998Medtronic, Inc.Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathyUS5755736Jul 16, 1997May 26, 1998Medtronic, Inc.Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmiasUS5755737Dec 13, 1996May 26, 1998Medtronic, Inc.Method and apparatus for diagnosis and treatment of arrhythmiasUS5776164Oct 11, 1996Jul 7, 1998Ela Medical S.A.Method and apparatus for defibrillation of the atriumUS5776167Feb 27, 1996Jul 7, 1998Pacesetter, Inc.System and method for alleviating the effects of pacemaker crosstalkUS5788717Jul 11, 1995Aug 4, 1998Pacesetter, Inc.Atrial rate determination and atrial tachycardia detection in a dual-chamber implantable pacemakerUS5800464Oct 3, 1996Sep 1, 1998Medtronic, Inc.System for providing hyperpolarization of cardiac to enhance cardiac functionUS5800471Oct 20, 1997Sep 1, 1998Cardiac Pacemakers, Inc.Method for optimizing cardiac performance by determining the optimal pacing mode-AV delay from a transient heart rate signal for use in CHF, brady, and tachy/brady therapy devicesUS5814077May 12, 1997Sep 29, 1998Pacesetter, Inc.Pacemaker and method of operating same that provides functional atrial cardiac pacing with ventricular supportUS5814085Apr 16, 1997Sep 29, 1998Medtronic, Inc.Rate stabilization pacemakerUS5836975Jun 5, 1997Nov 17, 1998Medtronic, Inc.Method and apparatus for diagnosis and treatment of arrhythmiasUS5836987Mar 12, 1997Nov 17, 1998Cardiac Pacemakers, Inc.Apparatus and method for optimizing cardiac performance by determining the optimal timing interval from an accelerometer signalUS5846263Dec 13, 1996Dec 8, 1998Medtronic, Inc.Cardiac pacemakerUS5855593Jun 12, 1997Jan 5, 1999Medtronic, Inc.Prioritized rule based method and apparatus for diagnosis and treatment for arrhythmiasUS5861007Feb 26, 1997Jan 19, 1999Medtronic, Inc.Adaptive search AV and auto PVARP adaptation to same with additional benefitUS5873895Aug 3, 1998Feb 23, 1999Pacesetter, Inc.Pacemaker and method of operating same that provides functional atrial cardiac pacing with ventricular supportUS5873897Sep 19, 1997Feb 23, 1999Sulzer Intermedics Inc.Method and apparatus for dual chambered tachyarrhythmia classification and therapyUS5893882Dec 17, 1996Apr 13, 1999Medtronic, Inc.Method and apparatus for diagnosis and treatment of arrhythmiasUS5897575Oct 24, 1997Apr 27, 1999Pacesetter, Inc.Arrhythmia classification system with reliability indication that allows for low quality input signals in pacemakersUS5928271Feb 25, 1998Jul 27, 1999Medtronic, Inc.Atrial anti-arrhythmia pacemaker and method using high rate atrial and backup ventricular pacingUS5931857Mar 24, 1998Aug 3, 1999Medtronic, Inc.Method and apparatus for diagnosis and treatment of arrhythmiasUS5935081Jan 20, 1998Aug 10, 1999Cardiac Pacemakers, Inc.Long term monitoring of acceleration signals for optimization of pacing therapyUS5944744Feb 6, 1998Aug 31, 1999Sulzer Intermedics Inc.Medical deviceUS5951592Nov 21, 1997Sep 14, 1999Pacesetter, Inc.Apparatus and method for applying antitachycardia therapy based on ventricular stabilityUS5978707Oct 8, 1997Nov 2, 1999Cardiac Pacemakers, Inc.Apparatus and method for treating ventricular tachyarrhythmiasUS5978710Jan 23, 1998Nov 2, 1999Sulzer Intermedics Inc.Implantable cardiac stimulator with safe noise modeUS5983138Apr 4, 1997Nov 9, 1999Cardiac Pacemakers, Inc.Device and method for ventricular tracking and pacingUS5987356Aug 12, 1998Nov 16, 1999Medtronic, Inc.Method and apparatus for diagnosis and treatment of arrhythmiasUS5991656Sep 22, 1998Nov 23, 1999Medtronic, Inc.Prioritized rule based apparatus for diagnosis and treatment of arrhythmiasUS5999850Jul 21, 1997Dec 7, 1999Pacesetter, Inc.Pacemaker with safe R-wave synchronization during countershock conversion of atrial fibrillationUS6026320Jun 8, 1998Feb 15, 2000Cardiac Pacemakers, Inc.Heart rate variability as an indicator of exercise capacityUS6044298Oct 13, 1998Mar 28, 2000Cardiac Pacemakers, Inc.Optimization of pacing parameters based on measurement of integrated acoustic noiseUS6049735Mar 1, 1999Apr 11, 2000Cardiac Pacemakers Inc.Cardiac rhythm management device with detection and therapy for sudden syncopal eventsUS6052620Mar 25, 1998Apr 18, 2000Medtronic, Inc.Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmiasUS6081745Aug 17, 1998Jun 27, 2000Medtronic, Inc.Method and apparatus for treatment of arrhythmiasEP0033418A1Dec 12, 1980Aug 12, 1981Medtronic, Inc.Ventricular synchronised atrial pacemakerWO1997011745A1Aug 16, 1996Apr 3, 1997Medtronic IncModification of pacemaker tachy response based on ffrw sensingWO1998048891A1Apr 17, 1998Nov 5, 1998Cardiac Pacemakers IncApparatus and method for treating ventricular tachyarrhythmias* Cited by examinerNon-Patent CitationsReference1Ayers, G.M., et al., "Ventricular Proarrhythmic Effects of Ventricular Cycle Length and Shock Strength in a Sheep Model of Transvenous Atrial Defibrillation", Circulation, 89 (1), pp. 413-422, (Jan. 1994).2Duckers, H.J., et al., "Effective use of a novel rate-smoothing algorithm in atrial fibrillation by ventricular pacing", European Heart Journal, 18, pp. 1951-1955, (1997).3Fahy, G.J., et al., "Pacing Strategies to Prevent Atrial Fibrillation", Atrial Fibrillation, 14 (4), pp. 591-596, (Nov. 1996).4Greenhut, S., et al., "Effectiveness of a Ventricular Rate Stabilization Algorithm During Atrial Fibrillation in Dogs", Pace, Abstract, 1 p., (1996).5Harmony, Automatic Dual Chamber Pacemaker, Product Information and Programming Guide, Viatron Medical, Harmony Dual Chamber mentioned in publication Clinica, 467, p. 16, Sep. 11, 1991, "Rate Devices Impact Pacemaker Market", and Clinica, 417, p. 9, Sep. 5, 1990. "French CNH Equipment Approvals"., 22 p., (Date Unknown).6Heuer, H., et al., "Dynamic Dual-Chamber Overdrive Pacing with an Implantable Pacemaker System: A New Method for Terminating Slow Ventricular Tachycardia", Zeitschrift fur Kardiologie, 75, German Translation by the Ralph McElroy Translation Company, Austin, TX, 5 p., (1986).7Mehra, R., et al., "Prevention of Atrial Fibrillation/Flutter by Pacing Techniques", Interventional Electrophysiology, Second Edition, Chapter 34, Futura Publishing Company, Inc., pp. 521-544, (1996).8Metrix Model 3020 Implantable Atrial Defibrillator, Physician's Manual, InControl, Inc., Redmond, WA, pp. 4-24-4-27, (1998).9Metrix Model 3020 Implantable Atrial Defibrillator, Physician's Manual, InControl, Inc., Redmond, WA, pp. 4-24�4-27, (1998).10Wittkampf, F., et al., "Rate Stabilization by Right Ventricular Pacing in Patients with Atrial Fibrillation", Pace, 9, pp. 1147-1153, (1986).Referenced byCiting PatentFiling datePublication dateApplicantTitleUS6728572Aug 14, 2002Apr 27, 2004Cardiac Pacemakers, Inc.System and method for classifying cardiac complexesUS6978177Nov 14, 2000Dec 20, 2005Cardiac Pacemakers, Inc.Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timingUS6996434Aug 2, 2001Feb 7, 2006Cardiac Pacemakers, Inc.Method and system for verifying the integrity of normal sinus rhythm templatesUS7039461 *May 13, 2000May 2, 2006Cardiac Pacemakers, Inc.Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episodeUS7336996Mar 11, 2004Feb 26, 2008Cardiac Pacemakers, Inc.Rate regularization of cardiac pacing for disordered breathing therapyUS7364547Aug 19, 2004Apr 29, 2008Cardiac Pacemakers, Inc.Use of external respiratory therapy device to detect cardiac electrical activityUS7468040Aug 30, 2004Dec 23, 2008Cardiac Pacemakers, Inc.Methods and systems for implantably monitoring external breathing therapyUS7469697Jun 9, 2004Dec 30, 2008Cardiac Pacemakers, Inc.Feedback system and method for sleep disordered breathing therapyUS7572225Aug 17, 2004Aug 11, 2009Cardiac Pacemakers, Inc.Sleep logbookUS7653430Nov 28, 2005Jan 26, 2010Cardiac Pacemakers, Inc.Method and system for verifying the integrity of normal sinus rhythm templatesUS7668591Aug 20, 2004Feb 23, 2010Cardiac Pacemakers, Inc.Automatic activation of medical processesUS7678061Apr 15, 2004Mar 16, 2010Cardiac Pacemakers, Inc.System and method for characterizing patient respirationUS7697987Apr 26, 2006Apr 13, 2010Medtronic, Inc.Method and system for detecting cardiac arrhythmias during overdrive pacingUS7764997Nov 4, 2005Jul 27, 2010Cardiac Pacemakers, Inc.Method and apparatus for using atrial discrimination algorithms to determine optimal pacing therapy and therapy timingUS7981042Feb 14, 2008Jul 19, 2011Cardiac Pacemakers, Inc.Use of external respiratory therapy device to detect cardiac electrical activityUS7993279Jul 15, 2008Aug 9, 2011Cardiac Pacemakers, Inc.Methods and systems for implantably monitoring external breathing therapyUS8290588Mar 12, 2010Oct 16, 2012Medtronic, Inc.Method and system for detecting cardiac arrhythmias during overdrive pacingUS8600502Jun 5, 2012Dec 3, 2013Cardiac Pacemakers, Inc.Sleep state classification* Cited by examinerClassifications U.S. Classification607/9International ClassificationA61N1/39, A61N1/362, A61N1/368, A61N1/18Cooperative ClassificationA61N1/395, A61N1/3621, A61N1/3627, A61N1/3962, A61N1/3987, A61N1/3682European ClassificationA61N1/39M2, A61N1/362ALegal EventsDateCodeEventDescriptionMar 14, 2013FPAYFee paymentYear of fee payment: 12Aug 5, 2009FPAYFee paymentYear of fee payment: 8Sep 6, 2005FPAYFee paymentYear of fee payment: 4Jun 25, 2002CCCertificate of correctionRotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services©2012 Google